Quantifying the contribution of pathology to patient management: a review of pathology cases presented at a head and neck multidisciplinary meeting
Shu Wang(Georgetown Lombardi Comprehensive Cancer Center), Ruta Gupta(Cedars-Sinai Medical Center), Michael Boyer(Chris O’Brien Lifehouse), James Wykes(The University of Sydney), Jonathan R. Clark(The University of Sydney), Paul McKenzie(The University of Sydney), Chris Milross(Chris O’Brien Lifehouse)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k